Tax Imposed by Chapters 11, 17, or 30 of Title 44

The structural integrity of Rhode Island’s research and development (R&D) incentive program relies on the deliberate integration of tax credits into the broader framework of Title 44 of the Rhode Island General Laws. By explicitly cross-referencing Chapters 11, 17, and 30, the General Assembly created a multi-channel incentive system designed to reach every significant segment of the state’s economy. Chapter 11 serves as the primary taxing authority for business corporations, while Chapter 17 addresses the unique premium-based tax structure of the insurance industry. Chapter 30 captures the personal income tax obligations of individual practitioners and, critically, the owners of pass-through entities such as S-corporations and partnerships. This tripartite linkage ensures that regardless of the legal form a business assumes, its investment in scientific inquiry and laboratory experimentation in Rhode Island is eligible for substantial fiscal relief, provided the activities and assets meet the rigorous definitions adopted from the federal Internal Revenue Code. The effectiveness of these credits is further moderated by statutory floors—such as the corporate minimum tax—and caps, most notably the 50% liability limitation applicable to the research expense credit.

The Three Pillars of Taxation: Chapters 11, 17, and 30

To understand the context of the R&D credit, one must first deconstruct the “tax imposed” by the three specific chapters mentioned in the statutes. Each chapter represents a distinct jurisdictional domain with its own set of definitions, rates, and filing requirements, yet they are unified under the R&D credit provisions of § 44-32-2 and § 44-32-3.

Chapter 11: Business Corporation Tax

Chapter 11 of Title 44 is the foundational statute for taxing the net income of entities organized as corporations or associations exercising corporate functions within Rhode Island. For most research-intensive firms, this is the primary “tax imposed” that the R&D credit seeks to alleviate. Under § 44-11-2, the state imposes an annual tax on the net income of every corporation derived from sources within the state. For tax years beginning on or after January 1, 2015, this rate is fixed at seven percent (7%) of net income.

The “tax imposed” by Chapter 11 includes several nuances that affect R&D credit utilization. For example, “net income” is defined as the taxable income as reported on federal Form 1120, subject to specific Rhode Island additions and subtractions. Furthermore, the statute provides for a minimum tax floor, which serves as a critical boundary for credit application. For tax years beginning on or after January 1, 2017, the tax imposed shall not be less than four hundred dollars ($400). The research credits are prohibited from reducing the corporate liability below this statutory minimum.

Within the corporate domain, the R&D credit also interacts with specialized entities such as Captive Real Estate Investment Trusts (Captive REITs). A Captive REIT is defined as a corporation, trust, or association considered a REIT under Section 856 of the Internal Revenue Code that is not regularly traded on an established securities market and is controlled by a single entity. Such entities are required to file Form RI-1120C and add back dividends paid to their federal taxable income before applying any credits, including R&D incentives.

Chapter 17: Taxation of Insurance Companies

Chapter 17 focuses on insurance companies, which are generally taxed on their gross premiums rather than their net income. The “tax imposed” under this chapter is reported primarily on Form T-71, the Insurance Companies Tax Return of Gross Premiums. The inclusion of Chapter 17 in the R&D credit framework reflects a specialized policy objective: encouraging the insurance sector to invest in research regarding loss prevention.

Under § 44-32-2(b) and § 44-32-3(b)(2), property and casualty insurance companies are granted a unique expansion of the “research and development” definition. For these entities, research and development includes methods and ways of preventing or reducing losses from fire and other perils. This industry-specific provision allows insurers to claim credits for laboratory work and experimental equipment that might not otherwise qualify under the standard federal definitions used by non-insurance corporations.

Chapter 30: Personal Income Tax

Chapter 30 governs the personal income tax imposed on the Rhode Island income of every individual, estate, and trust. While corporations are the traditional claimants of R&D credits, Chapter 30 is the essential conduit for the incentive to reach small businesses and startups organized as pass-through entities. Partnerships are not subject to the personal income tax directly; instead, the partners are liable in their separate or individual capacities.

When an R&D credit is generated by a partnership, joint venture, or small business corporation (S-corporation), the credit is “divided in the same manner as income”. This means the credit flows through to the individual partners or shareholders, who then use it to offset the personal income tax imposed on them under Chapter 30. For individuals, the R&D credit is nonrefundable, but any amount that exceeds the individual’s tax for a given year may be carried forward for a maximum of seven (7) years.

Tax Chapter	Primary Entity Type	Tax Basis	Form Used	Minimum Tax / Floor
Chapter 11	C-Corporations, REITs	Apportioned Net Income	RI-1120C	$400
Chapter 17	Insurance Companies	Gross Premiums	T-71	Variable by premium
Chapter 30	Individuals, PTE Owners	RI-Source Adjusted Gross Income	RI-1040	N/A

Structural Overview of the R&D Property Credit (§ 44-32-2)

The R&D Property Credit provides a 10% incentive for capital investments in tangible property used for research. The statutory language explicitly permits this credit to be used against the tax imposed by Chapters 11, 17, or 30.

Eligibility and Property Standards

To qualify for the 10% credit, the property must be tangible personal property or other tangible property, including buildings and structural components of buildings. The property must be “acquired, constructed, reconstructed, or erected” after July 1, 1994, and it must have a situs in Rhode Island. The asset must be depreciable under 26 U.S.C. § 167 or recovery property under 26 U.S.C. § 168, and it must have a useful life of at least three years.

The “principal use” requirement is a high bar. The property must be used primarily for research and development in the “experimental or laboratory sense”. This definition deliberately excludes activities such as ordinary quality control testing, efficiency surveys, management studies, consumer surveys, and promotional research. The credit is allowable in the year the property is first placed in service, which is determined based on the taxpayer’s depreciation practice.

Recapture and Add-Back Provisions

The law includes robust safeguards to ensure that property receiving the credit remains in qualified use. If property is disposed of or ceases to be in qualified use prior to the end of its useful life, the taxpayer must “add back” the difference between the credit taken and the credit allowed for actual use in the year of disposition.

For recovery property (3-year or 5-year property), if it is disposed of before 36 months, the credit is re-calculated based on the ratio of the months of qualified use to 36. For other property, the ratio is based on the months of actual use relative to the months of the property’s useful life. A significant safe harbor exists for long-term investments: if the property has been in qualified use for more than twelve (12) consecutive years, no add-back is required upon disposition.

Limitations on the Property Credit

A taxpayer is prohibited from taking the property credit if they have already taken a deduction for the same property under § 44-32-1 (the elective deduction for R&D facilities). Additionally, property that is leased to another person or corporation does not qualify for the credit. This prevents the “double-dipping” of tax benefits between a lessor and a lessee for the same physical asset.

For corporations, the property credit cannot reduce the tax due for the year to less than the $400 minimum fixed by § 44-11-2(e). Any unused portion of the property credit can be carried forward for a maximum of seven (7) years.

Property Credit Attribute	Statutory Requirement (§ 44-32-2)
Credit Percentage	10% of cost or federal basis
Minimum Useful Life	3 years
Geographical Requirement	Situs in Rhode Island
Recapture Safe Harbor	12 years of consecutive qualified use
Lease Restriction	Credit not allowed on leased property
Carryover Duration	7 years

Structural Overview of the Research Expense Credit (§ 44-32-3)

The Research Expense Credit is a tiered incentive aimed at the operational costs of innovation. Like the property credit, it applies against the tax imposed by Chapters 11, 17, and 30. However, its calculation and limitations differ significantly.

The Federal Connection and Incremental Approach

Rhode Island has “piggybacked” its expense credit on the federal research credit defined in 26 U.S.C. § 41. The terms “qualified research expenses” (QREs) and “base period research expenses” have the same meanings as they do for federal purposes, with the critical proviso that the expenses must have been incurred in Rhode Island.

The credit is based on the “excess” spending of the current year over the base period. To compute the Rhode Island credit, a taxpayer typically identifies their federal excess expenses from Form 6765 and then determines what portion of those expenses were specifically incurred in Rhode Island. Only the RI-source portion of the federal excess is eligible for the tiered state rates.

The Tiered Rate Structure

The Rhode Island expense credit utilizes a tiered system designed to provide a higher percentage of relief for smaller research budgets. Since January 1, 1998, the rates have been as follows:

• Tier 1: 22.5% on the first $111,111 of RI excess QREs (which results in a $25,000 credit).
• Tier 2: 16.9% on any RI excess QREs that exceed $111,111.

This tiered structure creates a powerful incentive for startups and small tech firms. For example, a company with exactly $111,111 in RI excess research spending would receive a $25,000 credit, representing an effective rate of 22.5%. A larger corporation with $1,000,000 in RI excess research spending would receive $25,000 (Tier 1) plus $150,212 (Tier 2), for a total credit of $175,212.

The 50% Liability Cap and Minimum Tax Floor

The most restrictive element of the expense credit is the 50% liability cap. Unlike the property credit, which can reduce tax liability down to the $400 minimum without an intermediate cap, the expense credit “shall not reduce the tax due for that year by more than fifty percent (50%) of the tax liability that would be payable”.

For corporations, this means that even if a taxpayer has enough R&D credits to eliminate their entire tax bill, they can only use them to offset half of their liability, and they still cannot go below the $400 minimum tax. For individuals under Chapter 30, the credit is similarly limited to 50% of the tax liability. Any credit that cannot be used due to these limitations may be carried forward for up to seven (7) years.

Tier	Basis Amount (Excess RI QREs)	Credit Rate	Credit Amount
Tier 1	First $111,111	22.5%	$25,000
Tier 2	Amounts over $111,111	16.9%	Calculated on remainder

Local Revenue Office Guidance and Form Instructions

The Rhode Island Division of Taxation (the “Division”) provides detailed administrative guidance on how to report and claim these credits. Compliance with these procedures is essential to ensure the credit is not disallowed during the processing of the return.

Form RI-7695E and Schedule B-CR

The primary form for calculating the expense credit is Form RI-7695E, Research & Development Expense Credit. This form mirrors the logic of federal Form 6765. Taxpayers must enter their federal QREs and base amounts, determine the federal excess, and then calculate the RI-source portion.

Once the credit is calculated on Form RI-7695E, the allowable amount (considering the 50% cap) is transferred to Schedule B-CR, the Business Entity Credit Schedule. This schedule serves as a summary of all business credits claimed by the entity. The Division requires that both Form RI-7695E and Schedule B-CR be attached to the primary return (such as Form RI-1120C or Form T-71).

Tracing Protocols and Consolidated Returns

The Division maintains strict guidance on the “tracing” of credits in a consolidated environment. Under § 44-32-3(e), the credit is only allowed against the tax of the specific corporation in a consolidated return that actually qualifies for the credit. It cannot be used to offset the tax of other affiliates in the group.

In the case of combined reporting, which is mandatory for unitary businesses in Rhode Island, the Division provides “Worksheet 1” to help calculate the individual tax liability of each member of the combined group. Taxpayers must determine the “Individual Total Credit” for each member and then limit the credit based on that specific member’s share of the group’s total tax. The result of the credit application for any individual member cannot be less than the $400 minimum tax.

Audit and Documentation Expectations

The Division’s guidance emphasizes the importance of documentation to support the RI-situs of the research. Taxpayers are advised to retain project-level records that tie the expenses reported on Form RI-7695E back to the scientific activities conducted within Rhode Island. Audit guidelines suggest retaining records for at least four years and ensuring that all wages, supplies, and contract research costs are substantiated by contemporaneous logs and payroll records.

For property credits, taxpayers must be prepared to prove “principal use.” This often requires maintaining logs for equipment and demonstrating that research was the primary activity performed in a specific building or laboratory for which the 10% credit was claimed.

Ordering of Credits and the Interaction of Limitations

The Rhode Island statutes and the Division’s regulations establish a specific order in which tax credits must be applied. This hierarchy is crucial because the 50% cap and the minimum tax floor are applied at different stages of the calculation.

The Statutory Hierarchy

Under § 44-32-3(c) and (d), and reinforced by Regulation 280-RICR-20-20-2, the credits must be used in the following sequence:

1. Investment Tax Credit (ITC): Credits under § 44-31-1 for manufacturing or other property must be taken first.
2. R&D Property Credit: The 10% credit under § 44-32-2 is taken after the ITC but before the research expense credit.
3. R&D Expense Credit: This credit is taken last among the R&D-related incentives.

The logic behind this hierarchy is that the property-based credits (ITC and § 44-32-2) are generally more restrictive in their “useful life” and “recapture” rules, while the expense credit (§ 44-32-3) is subject to the additional 50% liability cap. By using the property credits first, a taxpayer can reduce their liability to the absolute floor ($400) more efficiently. The expense credit is then applied to whatever liability remains, subject to its own 50% limitation.

Impact of Other Credits

If a taxpayer also claims an Enterprise Zone Business Credit, that credit must be used before the R&D expense credit. The Division provides specific examples (e.g., “Taxpayer F”) where the interplay of multiple credits with the 50% cap is demonstrated. In these cases, the 50% cap is typically calculated based on the tax “otherwise payable” after the prior credits in the sequence have been applied.

Credit Order	Credit Type	Statutory Authority	Primary Constraint
1st	Investment Tax Credit	§ 44-31-1	$400 Min Tax Floor
2nd	R&D Property Credit	§ 44-32-2	$400 Min Tax Floor
3rd	R&D Expense Credit	§ 44-32-3	50% Cap AND $400 Floor

Comprehensive Application Example: Biotech Innovations, LLC

To illustrate the meaning of “tax imposed by chapters 11 or 30” in a practical context, consider a hypothetical biotechnology firm, Biotech Innovations, LLC. This entity is organized as a partnership with two equal partners: Partner A (a C-corporation) and Partner B (an individual).

Phase 1: Entity-Level Credit Generation

In 2024, Biotech Innovations, LLC conducts significant research in its Providence laboratory.

• Federal QREs: $600,000.
• Federal Base Amount: $400,000.
• Federal Excess: $200,000.
• RI-Situs Portion of Excess: $200,000 (100% of research performed in RI).
• Capital Investment: $100,000 in specialized lab equipment (useful life 5 years, RI situs).

Step A: Calculate Property Credit (§ 44-32-2)

Credit_Prop = $100,000 x 0.10 = $10,000

Step B: Calculate Expense Credit (§ 44-32-3)

• Tier 1 (First $111,111): $111,111 x 0.225 = $25,000.
• Tier 2 (Remainder): ($200,000 – $111,111) x 0.169 = $15,022.24.
• Total Expense Credit: $25,000 + $15,022.24 = $40,022.24.

Phase 2: Credit Division and Pass-Through

Under § 44-32-2(k) and § 44-32-3(f), the credits are divided between the partners in the same manner as income.

• Partner A (Corp): $5,000 Property Credit; $20,011.12 Expense Credit.
• Partner B (Indiv): $5,000 Property Credit; $20,011.12 Expense Credit.

Phase 3: Application to Tax Imposed

Partner A (Chapter 11 Business Corporation Tax)

Partner A has a 2024 RI tax liability of $30,000 (after apportionment and before credits).

1. Apply Property Credit: $30,000 – $5,000 = $25,000 remaining liability.
2. Apply 50% Cap to Expense Credit: The 50% cap is applied to the remaining liability. $25,000 x 0.50 = $12,500.
3. Determine Allowable Expense Credit: Partner A has $20,011.12 in expense credits, but can only use $12,500 this year.
4. Final Tax Paid: $25,000 – $12,500 = $12,500. (This is above the $400 floor).
5. Carryforward: $20,011.12 – $12,500 = $7,511.12 (available for 7 years).

Partner B (Chapter 30 Personal Income Tax)

Partner B has a 2024 RI personal income tax liability of $10,000.

1. Apply Property Credit: $10,000 – $5,000 = $5,000 remaining liability.
2. Apply 50% Cap to Expense Credit: $5,000 x 0.50 = $2,500.
3. Final Tax Paid: $5,000 – $2,500 = $2,500.
4. Carryforward: $20,011.12 – $2,500 = $17,511.12 (available for 7 years).

Legislative Evolution and the 2026 Sunset Provisions

The legal landscape regarding the “tax imposed” and the R&D credit is subject to significant changes enacted in the Fiscal Year 2026 Budget Bill (H5076/c. 278). These changes reflect a policy shift in how the state balances innovation incentives against revenue stability.

The Sunset of the Property Credit

The most impactful change is the sunset of the R&D Property Credit under § 44-32-2. Credits for research and development property acquired, constructed, reconstructed, or erected after July 1, 1994, will no longer be allowed for tax years beginning on or after January 1, 2026. This effectively terminates the 10% property-based incentive for any new capital investments made in 2026 and beyond.

However, the legislature included a transition rule: any property credits allowed for tax years ending on or before December 31, 2025, may continue to be carried forward into future tax years. This preserves the value of existing credits while closing the door on new property-based claims.

The Extension of the Expense Credit Carryover

While the property credit is sunsetting, the Research Expense Credit (§ 44-32-3) has been modified to provide a longer-term benefit. For tax years beginning on or after January 1, 2026, the allowable carryover period for unused research expense credits is extended from seven (7) years to fifteen (15) years.

This extension is a significant win for startups and biotechnology firms, which often experience long periods of losses (and thus zero tax liability) during the clinical trial and development phases. A fifteen-year carryover aligns more closely with the federal 20-year period and ensures that these companies can eventually derive benefit from the credits they earn today once they become profitable. The 50% liability cap and the minimum tax floor for corporations remain in effect under the new legislation.

Decoupling and the Section 174A Adjustment

Another critical development in RI revenue guidance is the state’s reaction to federal changes in the treatment of R&D expenses under Section 174. Rhode Island has historically decoupled from certain federal accelerated depreciation and amortization rules.

For tax year 2025 and beyond, the Division of Taxation has introduced Schedule 174A. This worksheet is required for taxpayers who did not elect to amortize Section 174 research and development expenditures on their federal return. If a taxpayer fully expenses domestic R&D costs at the federal level, they may be required to add back the “accelerated” amount for Rhode Island purposes, effectively requiring state-level amortization. This creates a temporary “add-back” to the tax imposed by Chapters 11 and 30, which the R&D credits can then be used to offset.

Change Event	Provision Impacted	Effective Date	New Carryover / Policy
Sunset	Property Credit (§ 44-32-2)	Jan 1, 2026	No new credits; carryforward only
Extension	Expense Credit (§ 44-32-3)	Jan 1, 2026	Carryover increased to 15 years
Decoupling	Section 174 Amortization	Jan 1, 2025	Mandatory add-back for non-amortizers
Min Tax	Chapter 11 Corporations	Current	Permanent $400 floor

Final Thoughts

The integration of R&D tax credits within the framework of Chapters 11, 17, and 30 of Title 44 demonstrates a sophisticated attempt by the state of Rhode Island to incentivize innovation through the tax code. By tying the credits directly to the primary corporate and personal tax liabilities, the state ensures that the incentives are accessible to a wide variety of taxpayers, while simultaneously maintaining a revenue floor through the minimum tax and the 50% liability cap.

For taxpayers and practitioners, the “meaning” of these statutory references is found in the rigorous ordering and apportionment rules required by the Division of Taxation. The credit for research expenses is not merely a percentage of spending; it is an incremental reward based on federal excess, limited by state-specific ceilings, and carefully tracked through tracing protocols in consolidated filings. With the impending 2026 sunset of the property credit and the extension of the expense credit carryforward, taxpayers must re-evaluate their capital investment strategies and research cycles. Ensuring that all property is “placed in service” before the 2026 deadline is paramount for property credit eligibility, while the expanded 15-year carryover for expenses offers a more stable long-term outlook for the state’s growing biotechnology and innovation sectors. Compliance with the Division’s evolving guidance, particularly concerning Schedule 174A and Form RI-7695E, remains the definitive requirement for successfully leveraging these incentives against the tax imposed by the state.